1.0Annual Reporthttps://www.ipsen.com/annualreportkonstantinoskampanoshttps://www.ipsen.com/annualreport/author/konstantinoskampanos/A conversation with David Loewrich600338<blockquote class="wp-embedded-content" data-secret="tWisFdzaM7"><a href="https://www.ipsen.com/annualreport/a-conversation-with-david-loew/">A conversation with David Loew</a></blockquote><iframe sandbox="allow-scripts" security="restricted" src="https://www.ipsen.com/annualreport/a-conversation-with-david-loew/embed/#?secret=tWisFdzaM7" width="600" height="338" title="“A conversation with David Loew” — Annual Report" data-secret="tWisFdzaM7" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"></iframe><script>
/*! This file is auto-generated */
!function(d,l){"use strict";l.querySelector&&d.addEventListener&&"undefined"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!/[^a-zA-Z0-9]/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),o=l.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),c=new RegExp("^https?:$","i"),i=0;i<o.length;i++)o[i].style.display="none";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute("style"),"height"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):"link"===t.message&&(r=new URL(s.getAttribute("src")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener("message",d.wp.receiveEmbedMessage,!1),l.addEventListener("DOMContentLoaded",function(){for(var e,t,s=l.querySelectorAll("iframe.wp-embedded-content"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute("data-secret"))||(t=Math.random().toString(36).substring(2,12),e.src+="#?secret="+t,e.setAttribute("data-secret",t)),e.contentWindow.postMessage({message:"ready",secret:t},"*")},!1)))}(window,document);
//# sourceURL=https://www.ipsen.com/annualreport/wp-includes/js/wp-embed.min.js
</script>
2025 marked five years of Focus. Together. For patients and society. Guided by this strategy, we have embarked on exciting new partnerships, expanded our pipeline and portfolio and shared promising data from our clinical trials. All of this broadened the range of options for patients living with difficult-to-treat conditions in oncology, rare disease and neuroscience.David Loew, Ipsen’s CEO, reflects on how we translate strategy into results.